Jeffrey Stein - Mar 15, 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/20/2024, 06:46 PM
Previous filing
Mar 12, 2024
Next filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDTX Common Stock 1.15M Mar 15, 2024 Direct
holding CDTX Common Stock 332K Mar 15, 2024 By trust
holding CDTX Common Stock 42K Mar 15, 2024 By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Employee Stock Option (right to buy) Award $0 +1.04M $0.00 1.04M Mar 15, 2024 Common Stock 1.04M $0.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.